You are invited to participate in the 52nd NCDEU: An Annual Meeting Sponsored by ASCP to be held at the Biltmore in Phoenix, Arizona, May 29 - June 1, 2012, by submitting a proposal and attending the meeting.

The theme of this year’s meeting is “Identifying Common Targets across Brain Diseases – Implications for Treatment Development and Delivery.”

Detailed instructions about submitting your abstract, including topics of special interest, are available at www.NCDEUmeeting.org.

Submission deadline has passed.

2012 Submission Categories and Deadlines
Pharmaceutical Pipeline Presentations:	Deadlne Passed
Late-Breaking Research Reports:	Deadline Passed
New Investigator Award:	Deadline Passed
Posters:	Deadline Passed
Workshops and Panels Overall Proposals:	Deadline Passed
Workshops and Panels Individual Presenter Proposals:	Deadline Passed
Methodological Innovations in Clinical Trials Workshop:	Deadline Passed
Individual Research Reports:	Deadline Passed

Submission deadline has passed.

The 2012 meeting will again include representatives from academia, the National Institutes of Health, Food and Drug Administration, European regulatory agencies and industry to discuss key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalized interventions based on biomarkers orgenetic information.  A Steering Committee chaired by William Potter and Nina Schooler with representation of the sectors that are part of the NCDEU community will lead the direction of the meeting. Representatives from the FDA, EMA, NIMH, NIDA, NIAAA, the pharmaceutical industry and academia comprise the 2012 Steering Committee.   A Program Committee under the leadership of Dr. David Kupfer and Dr. Carlos Zarate will be responsible for review of all program submissions.

 

Join the NCDEU listserv
to get e-mail updates on meeting activities.